Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?

Εμφάνιση άλλων εκδόσεων (1)

Introduction: Neuromyelitis optica (NMO) is a severe demyelinating disease that preferentially involves spinal cord and optic nerve. It is part of a spectrum of neurological conditions associated with antibodies to aquaporin-4 (AQP4). This study investigates the role of MRI where novel, more sensiti...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Downer, J, Leite, M, Carter, R, Palace, J, Küker, W, Quaghebeur, G
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2012

Παρόμοια τεκμήρια

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
ανά: Downer, J, κ.ά.
Έκδοση: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
ανά: Jarius, S, κ.ά.
Έκδοση: (2007)

Neuromyelitis Optica (NMO) — Study Review
ανά: Justyna Chojdak-Łukasiewicz
Έκδοση: (2021-06-01)

Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks
ανά: Murchison, A, κ.ά.
Έκδοση: (2013)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
ανά: Littleton, E, κ.ά.
Έκδοση: (2006)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
ανά: Sudulagunta, Sreenivasa Rao, κ.ά.
Έκδοση: (2015-11-01)

NMO-DBr: the Brazilian Neuromyelitis Optica Database System
ανά: Marco A. Lana-Peixoto, κ.ά.
Έκδοση: (2011-08-01)

Differential diagnosis of neuromyelitis optica spectrum disorders
ανά: Sung-Min Kim, κ.ά.
Έκδοση: (2017-07-01)

CAN MRI BE USED AS A DIAGNOSTIC TOOL IN NEUROMYELITIS OPTICA SPECTRUM DISORDER?
ανά: Matthews, L, κ.ά.
Έκδοση: (2012)

Magnetic resonance imaging in neuromyelitis optica.
ανά: Tackley, G, κ.ά.
Έκδοση: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
ανά: Matthews, L, κ.ά.
Έκδοση: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
ανά: Matthews, L, κ.ά.
Έκδοση: (2013)

Neuromyelitis optica spectrum disorder and multiple sclerosis can be distinguished on the basis of MRI brain lesion characteristics
ανά: Matthews, L, κ.ά.
Έκδοση: (2012)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
ανά: Kim, W, κ.ά.
Έκδοση: (2012)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
ανά: Jacob, A, κ.ά.
Έκδοση: (2009)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
ανά: Collongues, N, κ.ά.
Έκδοση: (2013)

Racial differences in neuromyelitis optica spectrum disorder
ανά: Kim, S, κ.ά.
Έκδοση: (2018)

Delayed diagnosis of the neuromyelitis optica spectrum disorder
ανά: S. A. Dzhukkaeva, κ.ά.
Έκδοση: (2023-08-01)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
ανά: Kitley, J, κ.ά.
Έκδοση: (2014)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
ανά: Nour, M, κ.ά.
Έκδοση: (2014)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
ανά: Jarius, S, κ.ά.
Έκδοση: (2007)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
ανά: Jarius, S, κ.ά.
Έκδοση: (2007)

Neuromyelitis optica spectrum disorder
ανά: Simon Broadley, κ.ά.
Έκδοση: (2017-09-01)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
ανά: George, J, κ.ά.
Έκδοση: (2012)

The evolving clinical spectrum of neuromyelitis optica
ανά: Viegas, S, κ.ά.
Έκδοση: (2008)

Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
ανά: Mohammad Hossein Harirchian, κ.ά.
Έκδοση: (2015-02-01)

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
ανά: Matthews, L, κ.ά.
Έκδοση: (2013)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
ανά: Akman-Demir, G, κ.ά.
Έκδοση: (2008)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
ανά: Tarso Adoni, κ.ά.
Έκδοση: (2008-06-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
ανά: Viegas, S, κ.ά.
Έκδοση: (2009)

Use of mitoxantrone in neuromyelitis optica.
ανά: Kitley, J, κ.ά.
Έκδοση: (2011)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
ανά: Kitley, J, κ.ά.
Έκδοση: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
ανά: Kitley, J, κ.ά.
Έκδοση: (2013)

Pediatric neuromyelitis optica spectrum disorder
ανά: Aman Mehta
Έκδοση: (2024-01-01)

Hypersomnia in Neuromyelitis Optica Spectrum Disorders
ανά: Hasan Can Güdek, κ.ά.
Έκδοση: (2024-06-01)

Neuromyelitis optica spectrum disorders in children
ανά: N. F. Akhmetgaleeva, κ.ά.
Έκδοση: (2024-08-01)

Relapsing neuromyelitis optica spectrum disorder
ανά: M Lakshmi Lavanya, κ.ά.
Έκδοση: (2021-01-01)

Neuromyelitis optica spectrum disorders: An update
ανά: Lekha Pandit
Έκδοση: (2015-01-01)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
ανά: Kitley, J, κ.ά.
Έκδοση: (2013)

Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder
ανά: Francis, A, κ.ά.
Έκδοση: (2024)